The sensing of circRNA with tetrahedral DNA nanostructure modified microfluidic chip
Analytica Chimica Acta · 2024
DOI: 10.1016/j.aca.2024.342951 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytica Chimica Acta, 2024. Verfasst von Shiliang He und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen, 518118, China. Electronic address: heshiliang@sztu…. Hauptthemen laut MEDLINE: RNA, Circular, DNA, Nanostructures. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Circular ribonucleic acids (circRNAs) are a type of covalently closed noncoding RNA with disease-relevant expressions, making them promising biomarkers for diagnosis and prognosis. Accurate quantification of circRNA in biological samples is a necessity for their clinical application. So far, methods developed for detecting circRNAs include northern blotting, reverse transcription quantitative polymerase chain reaction (RT-qPCR), microarray analysis, and RNA sequencing. These methods generally suffer from disadvantages such as large sample consumption, cumbersome process, low selectivity, leading to inaccurate quantification of circRNA. It was thought that the above drawbacks could be eliminated by the construction of a microfluidic sensor. RESULTS: Herein, for the first time, a microfluidic sensor was constructed for circRNA analysis by using tetrahedral DNA nanostructure (TDN) as the skeleton for recognition probes and target-initiated hybridization chain reaction (HCR) as the signal amplification strategy. In the presence of circRNA, the recognition probe targets the circRNA-specific backsplice junction (BSJ). The captured circRNA then triggers the HCR by reacting with two hairpin species whose ends were labeled with 6-FAM, producing long DNA strands with abundant fluorescent labels. By using circ_0061276 as a model circRNA, this method has proven to be able to detect circRNA of attomolar concentration. It also eliminated the interference of linear RNA counterpart, showing high selectivity towards circRNA. The detection process can be implemented isothermally and does not require expensive complicated instruments. Moreover, this biosensor exhibited good performance in analyzing circRNA targets in total RNA extracted from cancer cells. SIGNIFICANCE: This represents the first microfluidic system for detection of circRNA. The biosensor showed merits such as ease of use, low-cost, small sample consumption, high sensitivity and specificity, and good reliability in complex biological matrix, providing a facile tool for circRNA analysis and related disease diagnosis in point-of care application scenes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen, 518118, China. Electronic address: heshiliang@sztu.edu.cn.
- College of Health Science and Environmental Engineering, Shenzhen Technology University, Shenzhen, 518118, China.
- College of Pharmacy, Shenzhen Technology University, Shenzhen, 518118, China.
Zitieren
APA
He, S., Chen, L., Chen, Z., Zhang, G., Huang, Y., Zheng, H., Yang, Q., Mo, Z., Lin, X., & Wen, J. (2024). The sensing of circRNA with tetrahedral DNA nanostructure modified microfluidic chip. Analytica Chimica Acta. https://doi.org/10.1016/j.aca.2024.342951
Vancouver
He S, Chen L, Chen Z, Zhang G, Huang Y, Zheng H, et al. The sensing of circRNA with tetrahedral DNA nanostructure modified microfluidic chip. Analytica Chimica Acta. 2024. doi:10.1016/j.aca.2024.342951
BibTeX
@article{He2024,
author = {He, Shiliang and Chen, Lei and Chen, Zhuolang and Zhang, Guihao and Huang, Yongjin and Zheng, Huaxiao and Yang, Qing and Mo, Zhuoxi and Lin, Xinyi and Wen, Jiancheng},
title = {The sensing of circRNA with tetrahedral DNA nanostructure modified microfluidic chip},
journal = {Analytica Chimica Acta},
year = {2024},
doi = {10.1016/j.aca.2024.342951}
}
EUVIMED